Insud Pharma
Jaime Rivas Bardavio is an accomplished professional in corporate affairs and market access, currently serving on the Executive Commission of the Real Instituto Elcano and as Corporate Affairs Associate Director at Insud Pharma. With extensive experience in government affairs and institutional relations, Jaime has held key positions at companies such as Takeda Farmacéutica España and AbbVie, focusing on market access strategies and policy development. Additionally, Jaime has contributed to academia as Co-Director of the Master MAR at Talento-EPHOS and was a member of the Asociación de Profesionales de las Relaciones Institucionales (APRI). Jaime's educational background includes degrees in Law from Universidad de Zaragoza and an MBA from IE Business School, complemented by a Master in European Communities and training in Computers & Law from Queen's University of Belfast.
This person is not in any teams
Insud Pharma
5 followers
INSUD PHARMA operates across the entire pharmaceutical value chain, delivering specialized expertise and experience in scientific research, development, manufacturing, sales and marketing of a wide range of value-adding active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and branded pharmaceuticals, for human and animal health. While the main offices are located in Madrid, Lugano, Buenos Aires, INSUD PHARMA is acting worldwide, creating a broad and balanced manufacturing and commercial network across Europe, America, Asia and Africa, to address global opportunities and customers` needs in all major pharmaceutical markets. INSUD PHARMA's activity is organized in three synergistic business areas: Industrial (Chemo), Branded (Exeltis) and Biotech (mAbxience), with over 7,300 professionals in more than 50 countries, 18 state-of-the-art facilities, 15 specialized R&D centers, 12 commercial offices and more than 35 pharmaceutical affiliates, serving 1,150 customers in 96 countries around the world. INSUD PHARMA believes in innovation and sustainable development. Our commitment is to improve people`s health and quality of life, providing access to quality medicines at affordable prices, and to continuously expand our efforts and R&D investment to develop new and better therapies.